Chandikumar S. Elangbam
Safety Assessment
GlaxoSmithKline
Research Triangle Park
NC27709-3398
USA
Name/email consistency: high
- Drug-induced valvulopathy: an update. Elangbam, C.S. Toxicol. Pathol (2010)
- Review paper: Current strategies in the development of anti-obesity drugs and their safety concerns. Elangbam, C.S. Vet. Pathol. (2009)
- 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats. Elangbam, C.S., Job, L.E., Zadrozny, L.M., Barton, J.C., Yoon, L.W., Gates, L.D., Slocum, N. Exp. Toxicol. Pathol. (2008)
- Evaluation of glycosaminoglycans content and 5-hydroxytryptamine 2B receptor in the heart valves of Sprague-Dawley rats with spontaneous mitral valvulopathy--a possible exacerbation by dl-amphetamine sulfate in Fischer 344 rats?. Elangbam, C.S., Wehe, J.G., Barton, J.C., Krull, D.L., Nyska, A., Crabbs, T., Kissling, G.E. Exp. Toxicol. Pathol. (2006)
- 5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats. Elangbam, C.S., Lightfoot, R.M., Yoon, L.W., Creech, D.R., Geske, R.S., Crumbley, C.W., Gates, L.D., Wall, H.G. J. Histochem. Cytochem. (2005)